Antithrombotic effects of magnesium sulfate in in vivo experiments

International Journal of Hematology

Volumn 77, Issue 4, 2003, Pages 414-419

  Sheu, Joen R ^a   Hsiao, George ^a   Shen, Ming Y ^a   Lee, Yen M ^b   Yen, Mao H ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Arterial thrombosis; Fluorescein sodium; Magnesium sulfate; Occlusion time; Platelet plug formation

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; FLUORESCEIN SODIUM; MAGNESIUM SULFATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; IN VITRO STUDY; LUNG EMBOLISM; MESENTERIC ARTERY; MOUSE; NONHUMAN; OCCLUSION; RAT; THROMBOGENESIS;

EID: 0141792762     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02982655     Document Type: Article

References (22)

1. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T. Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science. 1984;223:1315-1317.
2. Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH. Cellular ions in hypertension, diabetes, and obesity: a nuclear magnetic resonance spectroscopic study. Hypertension. 1991;17:951-957.
3. Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabonowitz B. Magnesium in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol. 1995;75:321-323.
4. Shechter M, Hod H, Kaplinsky E, Rabinowitz B. The rationale of magnesium as alternative therapy for patients with acute myocardial infarction without thrombolytic therapy. Am Heart J. 1996;132:483-486.
5. Rasmussen HS, McNair P, Goransson L, Balslov S, Larsen OG, Aurup P. Magnesium deficiency in patients with and without acute myocardial infarction uncovered by an intravenous loading test. Arch Intern Med. 1988;148:329-332.
6. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. New Engl J Med. 1995;333:201-205.
7. Nadler J, Malayan S, Luong H. Evidence that intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care. 1992;15:835-841.
8. Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989;2:1215-1220.
9. Hass WK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New Engl J Med. 1989;321:501-507.
10. Hwang DL, Yen CF, Nadler JL. Effect of intracellular magnesium on platelet activation and intracellular calcium mobilization. Am J Hypertens. 1992;5:700-706.
11. Ravn HB, Vissinger H, Kristensen SD, Wennmalm A, Thygesen K, Husted SE. Magnesium inhibits platelet activity: an infusion study in healthy volunteers. Thromb Haemost. 1996;75:939-944.
12. Sheu JR, Hsiao G, Shen MY, et al. Mechanisms involved in the antiplatelet activity of magnesium in human platelets. Br J Haematol. 2002;119:1033-1041.
13. Sato M, Ohshima N. Platelet thrombus induced in vivo by filtered light and fluorescent dye in mesenteric microvessels of the rat. Thromb Res. 1984;35:319-334.
14. Sheu JR, Yen MH, Peng IC, Chang MC, Huang TF. Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in vivo by blocking glycoprotein IIb/IIIa complex. Eur J Pharmacol. 1995;294:231-238.
15. Sheu JR, Chao SH, Yen MH, Huang TF. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide, on platelet plug formation in mesenteric microvessels of mice. Thromb Haemost. 1994;72:617-621.
16. Nordoy A, Chandler AB. Platelet thrombosis induced by adenosine diphosphate in the rat. Scand J Haematol. 1964;1:16-25.
17. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990;16:1-20.
18. Sheu JR, Hung WC, Wu CH, et al. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation. 1999;99:3056-3062.
19. Sheu JR, Yen MH, Hung WC, Lee YM, Su CH, Huang TF. Triflavin inhibits platelet-induced vasocontraction in deendothelialized aorta. Arterioscler Thromb Vas Biol. 1997;17:3461-3468.
20. Callahan AB, Lutz BR, Fulton GP, Degelman J. Smooth muscle and thrombus thresholds to unipolar stimulation of small blood vessels. Angiology. 1960;11:35-39.
21. Pritchard JA. The use of magnesium sulfate in pre-eclampsia and eclampsia. J Reprod Med. 1979;23:107-114.
22. Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in pre-eclampsia. Am J Obstet Gynecol. 1984;150:728-733.